Neoplasms, Connective and Soft Tissue  >>  everolimus  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
everolimus / Generic mfg.
NCT00187174: Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors

Completed
1
41
US
Everolimus
St. Jude Children's Research Hospital, Novartis
Tumors, Brain Tumors, Rhabdomyosarcoma, Sarcoma, Soft Tissue
10/08
10/08
NCT00927966: RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms

Completed
1
21
US
RAD001, CP-751,871
Suzanne George, MD, Brigham and Women's Hospital, Novartis, Pfizer
Sarcoma, Solid Tumor
01/11
01/11

Download Options